Back
ESC Premium Access

Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy
Topic: Antiplatelet Drugs
Speaker: Doctor S. Shams (Blackpool, GB)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Sabeeh Shams

Blackpool Teaching Hospitals NHS Trust, Blackpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

17 more presentations in this session

Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants

Speaker: Mr A. Holt (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates

Speaker: Mr A. Holt (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual kinetic mechanism of action

Speaker: Mr Q. Ying (Ningbo, CN)

Access
Abstract
Slides
Thumbnail

Antifibrotic and anti-inflammatory effects of the selective nonsteroidal MR antagonist finerenone in preclinical pulmonary fibrosis

Speaker: Doctor M. Delbeck (Wuppertal, DE)

Access
Abstract
Slides
Thumbnail

Aspirin vs. P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation: insights from the AFIRE trial

Speaker: Assistant Professor H. Fukaya (Sagamihara, JP)

Access
Abstract
Slides
Thumbnail

Access the full session

Congress committee e-posters choice in pharmacology and pharmacotherapy

Speakers: Doctor S. Shams, Mr A. Holt, Mr A. Holt, Mr Q. Ying, Doctor M. Delbeck...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb